Management of Akathisia in Patients Taking Aripiprazole

Immediate Action Algorithm

The American College of Psychiatry recommends immediately reducing the dose or switching to quetiapine or olanzapine, and simultaneously initiating propranolol 10-30 mg two to three times daily as first-line pharmacological treatment for patients experiencing akathisia on aripiprazole 1
Clinicians should systematically assess for subjective restlessness and objective motor manifestations before adjusting any medications, as akathisia is frequently misdiagnosed as worsening psychosis, anxiety, or agitation 2

Lowering the aripiprazole dose while remaining within therapeutic range is a recommended first-line intervention, as most patients with aripiprazole-induced akathisia improve with dose reduction 1, 2
Switching to quetiapine or olanzapine, which have significantly lower akathisia risk, is also a recommended first-line intervention 1, 2
Initiating propranolol 10-30 mg two to three times daily is the most consistently effective pharmacological treatment for akathisia across all guidelines 1, 2, 3

Young patients and males have a higher risk for extrapyramidal symptoms, including akathisia 2
Systematically inquiring about suicidal thoughts before and after any dose adjustment or medication change is crucial, as akathisia with aripiprazole can precipitate acute suicidal ideation 2, 3

Consider clonazepam for symptomatic relief and to address the anxiety component of akathisia, providing moderate-strength evidence for benefit when first-line treatments are insufficient 2
Benzodiazepines, such as clonazepam, should be used with caution, as they are sedating and increase fall risk in mobile patients 5

Re-evaluate the need for adjunctive medications, like propranolol, after the acute phase, as many patients no longer require them during long-term therapy 2